HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
about
Protein release through nonlethal oncotic pores as an alternative nonclassical secretory pathwayThe C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T CellsThe Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell ApoptosisChemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulationHuman immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathwayHIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responsesHeparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seedsSecretion without GolgiEvidence that Par-4 participates in the pathogenesis of HIV encephalitisThe intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to exportThe inhibition of microRNAs by HIV-1 Tat suppresses beta catenin activity in astrocytesInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseMucociliary dysfunction in HIV and smoked substance abuseHIV Associated Neurocognitive DisordersBiocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesApolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature reviewThe Startling Properties of Fibroblast Growth Factor 2: How to Exit Mammalian Cells without a Signal Peptide at HandHIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicityHuman immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia culturesGlobal profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone functionApoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease GThe neuropathogenesis of AIDSSynergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitroThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionTherapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTProtein folding does not prevent the nonclassical export of FGF1 and S100A13The human metapneumovirus matrix protein stimulates the inflammatory immune response in vitroAnxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat.Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy.HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3.Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Perspective on Kaposi's sarcoma: facts, concepts, and conjectures.Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort studyIbudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cellsDifferential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor
P2860
Q21284185-C7550AF9-1C90-4D6E-8191-117ED8AA3D31Q22248066-DFEA7429-FF12-4444-88D8-3499E4F99F92Q22248069-101CD836-17C4-43DD-9676-F9A836A6E983Q22253485-BE78B8F7-FDB8-4192-B6D2-F74F7E710BDEQ24523677-E8616E5D-6D52-45E3-BC9C-189740AAB23CQ24541552-A5FA6FA6-E31F-40C4-AAF8-88BF23E90346Q24564896-78BF296C-907C-4DC0-ADAB-69FFB630EA3CQ24630644-6FB3008F-5740-473D-8202-F0E6A0551CA3Q24654691-D706C4D3-A573-4214-AB96-43552DB269F3Q24671184-C7900F93-14BC-4BDB-AC9B-B8F389BCD3F4Q24673957-7DB96CC5-D3AD-424E-A32A-E835A4B28516Q26750549-8B3C54E2-02CD-4BE4-BD5C-9D5F1D2C8249Q26770397-25028DC4-E971-4A92-9305-DA1728286B7CQ26777222-B6DEDCFB-6B8A-4E58-92EF-6A1A1C8618ECQ27023968-7BB7D760-A7AC-44BC-A7B1-A43406039EE2Q27333734-A5472D0F-3A51-4309-9DCE-4BB7EDF8E858Q27491003-ACC63753-BF9B-4515-8B54-A453204F8057Q28085435-15BE7638-0CCE-4C56-8DC9-794B17F3F92DQ28210557-0152FB2D-7183-4C52-B4D0-11DC0149462FQ28212110-00D4415E-CC8C-4C09-97EE-2CD190DFA37AQ28218547-00800C01-FAB1-40A2-9E52-3F7D1E300AE8Q28267535-803CEC5B-5AC0-45DC-9F9E-4AF22BE594E7Q28300983-5BEFBE3A-0F6D-49B5-AD60-7FF4AE57B6ACQ28354326-2DA99470-1D10-487D-A751-0AFAE454B87DQ28386344-DADAFB76-C87E-44BF-AD44-ADEE38920E1FQ28476094-0CEF0F76-3ACF-4401-9A95-868DF59B2285Q28511093-8C82F894-DA06-4556-AB55-3BBC22A2C8DCQ28741996-38602EC9-A5B5-4093-8F3F-E8442910B23EQ30410538-1CADB4D0-2D45-40AD-AF55-ED9BFE7FAD3AQ30497248-1ED4253F-466A-4C1F-A011-3706B3A32698Q33541775-9C4EE137-DDC6-4B04-88F6-4554D4826585Q33641330-72AA4FFC-8EBA-434C-AC52-8A7ECF80B05FQ33649838-B1B448AD-25CB-4D1E-A568-0F90037A8F63Q33724002-2BEF5C1B-E475-4979-8F00-5F8994874D6BQ33785321-705E2FFC-DF63-4DD1-8BED-101C9B9133C9Q33797102-C9B736A0-BA5B-4009-ABA1-B677A3F543B5Q33864926-0DCBB25F-0FFE-4BCC-93E2-C4D7CB380D3BQ33873538-0B14E956-D393-4799-A1E2-65B423F6E323Q33897742-2B4C5D0D-FA01-4627-AAA0-4737AFD95931Q33948194-2D78997C-C4E9-4D9B-B49C-21B18795BDAA
P2860
HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
HIV-1 Tat protein exits from c ...... ycans through its basic region
@ast
HIV-1 Tat protein exits from c ...... ycans through its basic region
@en
HIV-1 Tat protein exits from c ...... ycans through its basic region
@nl
type
label
HIV-1 Tat protein exits from c ...... ycans through its basic region
@ast
HIV-1 Tat protein exits from c ...... ycans through its basic region
@en
HIV-1 Tat protein exits from c ...... ycans through its basic region
@nl
prefLabel
HIV-1 Tat protein exits from c ...... ycans through its basic region
@ast
HIV-1 Tat protein exits from c ...... ycans through its basic region
@en
HIV-1 Tat protein exits from c ...... ycans through its basic region
@nl
P2093
P3181
P1433
P1476
HIV-1 Tat protein exits from c ...... ycans through its basic region
@en
P2093
P304
P3181
P356
10.1097/00002030-199712000-00006
P407
P577
1997-10-01T00:00:00Z